|
Market Cap (4-Jul) $738,750,080 (468th) |
Close (30-Jun) $0.55 |
Volume (30-Jun) 827,047 |
Shortsold (19-Jun) 41,649,705 (3.38%) (73rd) |
|
52w High $1.17 |
52w Low $0.335 |
P/E 6.75 |
EPS -0.43 |
OPT released this announcement to the ASX on 18 February 2022, 8:11. The announcement is not marked as price sensitive, and is 19 page(s) in length and 222.8kb in size.
You can view all announcements from OPT and see how they appear on a price chart on the announcements page.
At the date of this announcement, OPT was 3.230% short sold according to ASIC data. It was ranked the 52nd most shorted stock on the ASX. It remains ranked 73rd as of the latest reported data (19 June 2025).
| Other Recent Announcements from OPT | |
|---|---|
| Change in substantial holding | 23 June 2023, 16:51 |
| Final Director's Interest Notice MS | 9 June 2023, 8:16 |
| Initial Director's Interest Notice AT | 9 June 2023, 8:15 |
| Becoming a substantial holder | 18 February 2022, 8:11 |
| Change in substantial holding | 16 February 2022, 8:09 |
| Angiogenesis 2022 -Prof Cheung presentation of PCV data | 14 February 2022, 8:55 |
| Opthea data for OPT-302 in patients with PVC as presented | 14 February 2022, 8:25 |
You must be logged in to post a reply.
Opthea 